Oda, T., Nagata, H., Nakashima, Y., Nanishi, E., Takada, Y., Nishimura, M., . . . Ohga, S. (2019). Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease. The Journal of pediatrics, 214, 227-230. https://doi.org/10.1016/j.jpeds.2019.06.018
Chicago Style (17th ed.) CitationOda, Takuya, Hazumu Nagata, Yasutaka Nakashima, Etsuro Nanishi, Yui Takada, Manao Nishimura, Eiji Kubo, Ken Hatae, and Shouichi Ohga. "Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease." The Journal of Pediatrics 214 (2019): 227-230. https://doi.org/10.1016/j.jpeds.2019.06.018.
MLA (9th ed.) CitationOda, Takuya, et al. "Clinical Utility of Highly Purified 10% Liquid Intravenous Immunoglobulin in Kawasaki Disease." The Journal of Pediatrics, vol. 214, 2019, pp. 227-230, https://doi.org/10.1016/j.jpeds.2019.06.018.